Kenan K, Mack K, Paulozzi L Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med. 2012 Apr 10;6(2):e41-7. Print 2012.
Kitagawa T, Pitot HC Immunohistochemical demonstration of serine dehydratase in rat liver. Am J Pathol. 1975 Feb;78(2):309-18.
Kuehn BM Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA. 2007 Jan 17;297(3):249-51.
Miller C, Dadoo R, Kooser RG, Gorse J Electron spin resonance studies under dynamic mobile phase conditions on chemically modified silica. J Chromatogr. 1988 Dec 23;458:255-66.
Oakey RE Steroid sulphatase deficiency. J Endocrinol. 1987 Mar;112(3):341-3.
Stein BD, Gordon AJ, Sorbero M, Dick AW, Schuster J, Farmer C The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone. Drug Alcohol Depend. 2012 Jun 1;123(1-3):72-8. doi: 10.1016/j.drugalcdep.2011.10.016. Epub 2011 Nov 16.
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
